Startup Fundraisingβ€’

Candid Health Raises $120M for AI-Powered Revenue Cycle

Candid Health secures $120M Series D led by Sixth Street Growth, revolutionizing healthcare payments with autonomous revenue cycle management and AI.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Healthcare, Healthtech & Medtech, Technology, Software & Gaming in United States" are published.

Key Takeaways

  • Candid Health raised $120.0M (Series D) from Sixth Street, Oak HC/FT, 8VC, Y Combinator, First Round.
  • Sector: Healthcare, Healthtech & Medtech, Technology, Software & Gaming, Financial Services & Fintech.
  • Geography: United States.

Analysis

Candid Health, a pioneer in autonomous revenue cycle management for healthcare providers, has successfully closed a $120 million Series D funding round. The financing was led by Sixth Street Growth, with significant participation from existing investors including Oak HC/FT, 8VC, Y Combinator, and First Round. This substantial investment underscores the market's recognition of Candid's innovative approach to streamlining the complex financial operations within the healthcare sector.

The healthcare revenue cycle management industry, a market valued at an estimated $280 billion, has long been plagued by inefficiencies and legacy systems. Providers frequently grapple with increasing claim denials, which can result in substantial revenue loss – with nearly three-quarters of providers reporting a rise in denials and over 40% seeing more than 10% of their claims rejected outright. A significant portion of these denied claims, often exceeding 50%, are never resubmitted, leading practices to forfeit approximately 4-5% of their net revenue.

Candid Health distinguishes itself by tackling the root cause of payment delays and denials rather than merely remediating them. The company has developed a sophisticated platform that leverages agentic artificial intelligence and a deep understanding of over a thousand U.S. payor billing requirements. This allows Candid to meticulously construct and submit claims correctly from the outset, drastically reducing the likelihood of rejection. This proactive strategy contrasts sharply with traditional methods that rely heavily on manual appeals processes and costly administrative labor.

At the core of Candid's technology is a comprehensive knowledge graph, a continuously evolving model that integrates provider data, fee schedules, charge rules, and payor adjudication behaviors. This robust data foundation empowers Candid's AI agents to autonomously manage critical workflows such as eligibility verification, coding accuracy, and appeals, ensuring providers are paid accurately and promptly. This "information flywheel" effect, where each processed claim enhances the system's intelligence, creates a compounding advantage.

The impact of Candid's solution is evident in its customer outcomes. Clients are reporting industry-leading key performance indicators, including 95-99% first-pass claim resolution rates, an average payment cycle of under 20 days, and a reduction in manual collection efforts by approximately 40%. This translates directly into improved financial health for healthcare providers, allowing them to dedicate more resources to patient care.

The leadership team, co-founded by former Palantir executives Nick Perry and Doug Proctor, brings a unique blend of deep technical expertise and operational rigor. Their experience in building complex data infrastructure systems has been instrumental in developing Candid's first-principles approach to solving revenue cycle challenges. The company has demonstrated impressive growth, achieving 190% year-over-year growth in annual contracted run-rate revenue in 2025 and now serves over 200 leading medical groups, MSOs, and digital health companies.

This latest funding round is expected to accelerate Candid Health's mission to modernize healthcare payment infrastructure, further enhancing its AI capabilities and expanding its reach across the provider market. The investment signals strong confidence in the company's ability to address critical pain points in healthcare finance and drive greater efficiency throughout the system.